CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 406 of 865
Non-Antibody Products
Page 406 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Ipriflavone | An analytical reference standard categorized as an aromatase inhibitor and… | 1 mg | 26319-1 | More Info |
| Ipriflavone | An analytical reference standard categorized as an aromatase inhibitor and… | 5 mg | 26319-5 | More Info |
| Ipronidazole | A nitroimidazole antiprotozoal agent; dietary administration reduces H. me… | 10 mg | 35082-10 | More Info |
| Ipronidazole | A nitroimidazole antiprotozoal agent; dietary administration reduces H. me… | 25 mg | 35082-25 | More Info |
| Ipronidazole | A nitroimidazole antiprotozoal agent; dietary administration reduces H. me… | 5 mg | 35082-5 | More Info |
| Ipronidazole | A nitroimidazole antiprotozoal agent; dietary administration reduces H. me… | 50 mg | 35082-50 | More Info |
| Ipronidazole-d3 | An internal standard for the quantification of ipronidazole by GC- or LC-MS | 1 mg | 37194-1 | More Info |
| Ipronidazole-d3 | An internal standard for the quantification of ipronidazole by GC- or LC-MS | 5 mg | 37194-5 | More Info |
| Ipronidazole-d3 | An internal standard for the quantification of ipronidazole by GC- or LC-MS | 500 µg | 37194-500 | More Info |
| Ipsapirone | A partial agonist of 5-HT1A receptors (Ki = 10 nM in hippocampal membranes… | 10 mg | 39918-10 | More Info |
| Ipsapirone | A partial agonist of 5-HT1A receptors (Ki = 10 nM in hippocampal membranes… | 25 mg | 39918-25 | More Info |
| Ipsapirone | A partial agonist of 5-HT1A receptors (Ki = 10 nM in hippocampal membranes… | 5 mg | 39918-5 | More Info |
| Ipsapirone | A partial agonist of 5-HT1A receptors (Ki = 10 nM in hippocampal membranes… | 50 mg | 39918-50 | More Info |
| Ipsapirone (hydrochloride) | A partial agonist of serotonin 5-HT1A receptors (Ki = 10 nM in hippocampal… | 10 mg | 22075-10 | More Info |
| Ipsapirone (hydrochloride) | A partial agonist of serotonin 5-HT1A receptors (Ki = 10 nM in hippocampal… | 25 mg | 22075-25 | More Info |
| Ipsapirone (hydrochloride) | A partial agonist of serotonin 5-HT1A receptors (Ki = 10 nM in hippocampal… | 5 mg | 22075-5 | More Info |
| Ipsapirone (hydrochloride) | A partial agonist of serotonin 5-HT1A receptors (Ki = 10 nM in hippocampal… | 50 mg | 22075-50 | More Info |
| IPSU | An orexin receptor 2 antagonist (Ki = 14.13 nM); selective for OX2R over O… | 1 mg | 30007-1 | More Info |
| IPSU | An orexin receptor 2 antagonist (Ki = 14.13 nM); selective for OX2R over O… | 10 mg | 30007-10 | More Info |
| IPSU | An orexin receptor 2 antagonist (Ki = 14.13 nM); selective for OX2R over O… | 25 mg | 30007-25 | More Info |
| IPSU | An orexin receptor 2 antagonist (Ki = 14.13 nM); selective for OX2R over O… | 5 mg | 30007-5 | More Info |
| IPTG (dioxane free) | Induces protein expression where the gene is under the control of the lac… | 1 g | 15300-1 | More Info |
| IPTG (dioxane free) | Induces protein expression where the gene is under the control of the lac… | 10 g | 15300-10 | More Info |
| IPTG (dioxane free) | Induces protein expression where the gene is under the control of the lac… | 25 g | 15300-25 | More Info |
| IPTG (dioxane free) | Induces protein expression where the gene is under the control of the lac… | 5 g | 15300-5 | More Info |
| IQ-1 | A cell-permeable compound that maintains long-term mouse ESC pluripotency;… | 10 mg | 16153-10 | More Info |
| IQ-1 | A cell-permeable compound that maintains long-term mouse ESC pluripotency;… | 25 mg | 16153-25 | More Info |
| IQ-1 | A cell-permeable compound that maintains long-term mouse ESC pluripotency;… | 5 mg | 16153-5 | More Info |
| IQ-1 | A cell-permeable compound that maintains long-term mouse ESC pluripotency;… | 50 mg | 16153-50 | More Info |
| IQA | A CK2 inhibitor (IC50 = 0.39 µM); selective for CK2 over PKA, GSK3&b… | 1 mg | 35223-1 | More Info |
| IQA | A CK2 inhibitor (IC50 = 0.39 µM); selective for CK2 over PKA, GSK3&b… | 10 mg | 35223-10 | More Info |
| IQA | A CK2 inhibitor (IC50 = 0.39 µM); selective for CK2 over PKA, GSK3&b… | 25 mg | 35223-25 | More Info |
| IQA | A CK2 inhibitor (IC50 = 0.39 µM); selective for CK2 over PKA, GSK3&b… | 5 mg | 35223-5 | More Info |
| IQ-1S (free acid) | An inhibitor of NF-κB / AP-1 (IC50 = 2.3 µM in a reporter assa… | 10 mg | 29851-10 | More Info |
| IQ-1S (free acid) | An inhibitor of NF-κB / AP-1 (IC50 = 2.3 µM in a reporter assa… | 25 mg | 29851-25 | More Info |
| IQ-1S (free acid) | An inhibitor of NF-κB / AP-1 (IC50 = 2.3 µM in a reporter assa… | 5 mg | 29851-5 | More Info |
| IR 780 | A fluorescent probe for in vivo tumor cell imaging; ex / em = 780 / 799 nm… | 1 g | 31632-1 | More Info |
| IR 780 | A fluorescent probe for in vivo tumor cell imaging; ex / em = 780 / 799 nm… | 500 mg | 31632-500 | More Info |
| IR 783 | A fluorescent probe for in vivo tumor cell imaging; ex / em = 633 / 780 nm… | 100 mg | 31633-100 | More Info |
| IR 783 | A fluorescent probe for in vivo tumor cell imaging; ex / em = 633 / 780 nm… | 250 mg | 31633-250 | More Info |
| IR 783 | A fluorescent probe for in vivo tumor cell imaging; ex / em = 633 / 780 nm… | 50 mg | 31633-50 | More Info |
| IR-117-17 | An ionizable cationic and biodegradable amino lipid; nebulized administrat… | 10 mg | 40420-10 | More Info |
| IR-117-17 | An ionizable cationic and biodegradable amino lipid; nebulized administrat… | 5 mg | 40420-5 | More Info |
| IRAK Inhibitor 1 | An IRAK4 inhibitor (IC50 = 35 nM); selective for IRAK4 over JNK1 and JNK2… | 1 mg | 36637-1 | More Info |
| IRAK Inhibitor 1 | An IRAK4 inhibitor (IC50 = 35 nM); selective for IRAK4 over JNK1 and JNK2… | 10 mg | 36637-10 | More Info |
| IRAK Inhibitor 1 | An IRAK4 inhibitor (IC50 = 35 nM); selective for IRAK4 over JNK1 and JNK2… | 25 mg | 36637-25 | More Info |
| IRAK Inhibitor 1 | An IRAK4 inhibitor (IC50 = 35 nM); selective for IRAK4 over JNK1 and JNK2… | 5 mg | 36637-5 | More Info |
| IRAK Inhibitor 6 | An IRAK4 inhibitor (IC50 = 160 nM) | 1 mg | 33267-1 | More Info |
| IRAK Inhibitor 6 | An IRAK4 inhibitor (IC50 = 160 nM) | 10 mg | 33267-10 | More Info |
| IRAK Inhibitor 6 | An IRAK4 inhibitor (IC50 = 160 nM) | 5 mg | 33267-5 | More Info |
| IRAK-1/4 Inhibitor | A benzimidazole that selectively disrupts the activity of IRAK 1 and 4 (IC… | 1 mg | 17540-1 | More Info |
| IRAK-1/4 Inhibitor | A benzimidazole that selectively disrupts the activity of IRAK 1 and 4 (IC… | 10 mg | 17540-10 | More Info |
| IRAK-1/4 Inhibitor | A benzimidazole that selectively disrupts the activity of IRAK 1 and 4 (IC… | 25 mg | 17540-25 | More Info |
| IRAK-1/4 Inhibitor | A benzimidazole that selectively disrupts the activity of IRAK 1 and 4 (IC… | 5 mg | 17540-5 | More Info |
| IRAK4 Inhibitor 1 | An IRAK4 inhibitor (IC50 = 7 nM); reduces resiquimod-induced increases in… | 1 mg | 37548-1 | More Info |
| IRAK4 Inhibitor 1 | An IRAK4 inhibitor (IC50 = 7 nM); reduces resiquimod-induced increases in… | 10 mg | 37548-10 | More Info |
| IRAK4 Inhibitor 1 | An IRAK4 inhibitor (IC50 = 7 nM); reduces resiquimod-induced increases in… | 25 mg | 37548-25 | More Info |
| IRAK4 Inhibitor 1 | An IRAK4 inhibitor (IC50 = 7 nM); reduces resiquimod-induced increases in… | 5 mg | 37548-5 | More Info |
| IRAK4 Inhibitor 28 | An IRAK4 inhibitor (IC50 = 0.005 µM); selective for IRAK4 over IRAK1… | 1 mg | 40167-1 | More Info |
| IRAK4 Inhibitor 28 | An IRAK4 inhibitor (IC50 = 0.005 µM); selective for IRAK4 over IRAK1… | 10 mg | 40167-10 | More Info |
| IRAK4 Inhibitor 28 | An IRAK4 inhibitor (IC50 = 0.005 µM); selective for IRAK4 over IRAK1… | 25 mg | 40167-25 | More Info |
| IRAK4 Inhibitor 28 | An IRAK4 inhibitor (IC50 = 0.005 µM); selective for IRAK4 over IRAK1… | 5 mg | 40167-5 | More Info |
| Irbesartan | An insurmountable AT1 receptor antagonist (Ki = 1.3 nM); reduces blood pre… | 10 mg | 11952-10 | More Info |
| Irbesartan | An insurmountable AT1 receptor antagonist (Ki = 1.3 nM); reduces blood pre… | 100 mg | 11952-100 | More Info |
| Irbesartan | An insurmountable AT1 receptor antagonist (Ki = 1.3 nM); reduces blood pre… | 50 mg | 11952-50 | More Info |
| Irbesartan-d4 | An internal standard for the quantification of irbesartan by GC- or LC-MS | 1 mg | 25509-1 | More Info |
| Irbesartan-d4 | An internal standard for the quantification of irbesartan by GC- or LC-MS | 500 µg | 25509-500 | More Info |
| IRBP (1-20) (human, rat) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; increases the… | 1 mg | 36727-1 | More Info |
| IRBP (1-20) (human, rat) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; increases the… | 10 mg | 36727-10 | More Info |
| IRBP (1-20) (human, rat) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; increases the… | 25 mg | 36727-25 | More Info |
| IRBP (1-20) (human, rat) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; increases the… | 5 mg | 36727-5 | More Info |
| IRBP (651-670) (human) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; has been used… | 1 mg | 36953-1 | More Info |
| IRBP (651-670) (human) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; has been used… | 10 mg | 36953-10 | More Info |
| IRBP (651-670) (human) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; has been used… | 25 mg | 36953-25 | More Info |
| IRBP (651-670) (human) (trifluoroacetate salt) | A peptide inducer of experimental autoimmune uveoretinitis; has been used… | 5 mg | 36953-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile